Turnstone Biologics Corp. – NASDAQ:TSBX

Add to watchlist

$0.355

-0.15

-29.8%

Market closed

Open in about 16 hours

-79.35%

month

-79.35%

quarter

-82.73%

year

Market Cap	10.90M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-4.24

Revenue	N/A
EBITDA	-76.73M
Income	-74.89M
Revenue Q/Q	-100%
Revenue Y/Y	-100%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Turnstone Biologics Corp. Stock Forecast

M Q Y

Last Year

$0.5

Potential upside: 40.84%

Analysts Price target
Financials & Ratios estimates

Turnstone Biologics Corp. (NASDAQ:TSBX): Profit margin
Jun 2023	0	-21.49M
Sep 2023	0	-17.31M
Dec 2023	0	-16.45M
Mar 2024	0	-19.62M

Turnstone Biologics Corp. (NASDAQ:TSBX): Earnings per share (EPS)
2024-03-21	-0.86	-0.73
2024-05-13	-0.78	-0.85

Turnstone Biologics Corp. (NASDAQ:TSBX): Debt to assets
Jun 2023	74771000	195.37M	261.3%
Sep 2023	131312000	17.41M	13.26%
Dec 2023	112815000	14.14M	12.54%
Mar 2024	94390000	14.37M	15.23%

Turnstone Biologics Corp. (NASDAQ:TSBX): Cash Flow
Jun 2023	-14.69M	2.97M	-266K
Sep 2023	-18.78M	-42.26M	78.29M
Dec 2023	-15.50M	-5.30M	-169K
Mar 2024	-17.46M	14.09M	0

Turnstone Biologics Corp. alternative data

Turnstone Biologics Corp.
Employees

Turnstone Biologics Corp. (NASDAQ:TSBX): Employee count
Dec 2023	94
Jan 2024	94
Feb 2024	94
Mar 2024	80
Apr 2024	80
May 2024	80
Jun 2024	82
Jul 2024	82

Turnstone Biologics Corp.
Insider Trading

Turnstone Biologics Corp. (NASDAQ:TSBX): Insider trades (number of shares)
Period	Buy	Sel
Jul 2023	641666	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	25 Jul 2023	VERSANT VENTURES V, LLC 10 percent owner 10 percent owner	Common Stock	197,458	$12	$2,369,496
Purchase	25 Jul 2023	VERSANT VENTURES V, LLC 10 percent owner 10 percent owner	Common Stock	15,028	$12	$180,336
Purchase	25 Jul 2023	VERSANT VENTURES V, LLC 10 percent owner 10 percent owner	Common Stock	6,575	$12	$78,900
Purchase	25 Jul 2023	VERSANT VENTURES V, LLC 10 percent owner 10 percent owner	Common Stock	5,939	$12	$71,268
Purchase	20 Jul 2023	ORBIMED ADVISORS LLC director, 10 percent owner: director, 10 percent owner:	Common Stock	416,666	$12	$4,999,992

TSBX insider trading transactions

Turnstone Biologics Corp.
Latest News

Tuesday, 5 November 2024
09:01	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting	globenewswire.com
Thursday, 15 August 2024
11:57	Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study	benzinga.com
08:38	Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?	investorplace.com
Wednesday, 14 August 2024
16:05	Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights	globenewswire.com
16:01	Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer	globenewswire.com
Thursday, 8 August 2024
13:05	4 Stocks Under $5 To Buy Now	247wallst.com
Monday, 13 May 2024
17:01	Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	globenewswire.com
Wednesday, 8 May 2024
09:00	Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Turnstone Biologics Corp. stock today?

One share of Turnstone Biologics Corp. stock can currently be purchased for approximately $0.36.
When is Turnstone Biologics Corp.'s next earnings date?

Unfortunately, Turnstone Biologics Corp.'s (TSBX) next earnings date is currently unknown.
Does Turnstone Biologics Corp. pay dividends?

No, Turnstone Biologics Corp. does not pay dividends.
How much money does Turnstone Biologics Corp. make?

Turnstone Biologics Corp. has a market capitalization of 10.90M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 73.66% to 19.31M US dollars. Turnstone Biologics Corp. made a loss 55.2M US dollars in net income (profit) last year or -$0.85 on an earnings per share basis.
What is Turnstone Biologics Corp.'s stock symbol?

Turnstone Biologics Corp. is traded on the NASDAQ under the ticker symbol "TSBX".
What is Turnstone Biologics Corp.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Turnstone Biologics Corp.?

Shares of Turnstone Biologics Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Turnstone Biologics Corp. have?

As Jul 2024, Turnstone Biologics Corp. employs 82 workers, which is 3% more then previous quarter.
When Turnstone Biologics Corp. went public?

Turnstone Biologics Corp. is publicly traded company for more then 2 years since IPO on 21 Jul 2023.
What is Turnstone Biologics Corp.'s official website?

The official website for Turnstone Biologics Corp. is turnstonebio.com.
Where are Turnstone Biologics Corp.'s headquarters?

Turnstone Biologics Corp. is headquartered at 9310 Athena Circle, LA Jolla, CA.
How can i contact Turnstone Biologics Corp.?

Turnstone Biologics Corp.'s mailing address is 9310 Athena Circle, LA Jolla, CA and company can be reached via phone at +34 78975988.
What is Turnstone Biologics Corp. stock forecast & price target?

Based on 1 Wall Street analysts` predicted price targets for Turnstone Biologics Corp. in the last 12 months, the avarage price target is $0.5. The average price target represents a 40.84% change from the last price of $0.36.

Turnstone Biologics Corp.

turnstonebio.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

+34 78975988

9310 Athena Circle
LA Jolla, CA 92037

CIK: 0001764974
ISIN: US90042W1009
CUSIP: 90042W100